These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33815612)

  • 1. Impact of adipose tissue in chronic kidney disease development (Review).
    Miricescu D; Balan DG; Tulin A; Stiru O; Vacaroiu IA; Mihai DA; Popa CC; Enyedi M; Nedelea AS; Nica AE; Stefani C
    Exp Ther Med; 2021 May; 21(5):539. PubMed ID: 33815612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition and Obesity Impacts on Kidney Health.
    Wang AY; Kovesdy CP
    Contrib Nephrol; 2021; 199():24-42. PubMed ID: 34343991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue metabolic changes in chronic kidney disease.
    Serrano E; Shenoy P; Martinez Cantarin MP
    Immunometabolism (Cobham); 2023 Apr; 5(2):e00023. PubMed ID: 37128293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity associated hypertension: new insights into mechanism.
    Kang YS
    Electrolyte Blood Press; 2013 Dec; 11(2):46-52. PubMed ID: 24627704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral fat and attribute-based medicine in chronic kidney disease.
    Kataoka H; Nitta K; Hoshino J
    Front Endocrinol (Lausanne); 2023; 14():1097596. PubMed ID: 36843595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.
    Navaneethan SD; Kirwan JP; Remer EM; Schneider E; Addeman B; Arrigain S; Horwitz E; Fink JC; Lash JP; McKenzie CA; Rahman M; Rao PS; Schold JD; Shafi T; Taliercio JJ; Townsend RR; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):44-55. PubMed ID: 32798563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease.
    Teplan V; Vyhnánek F; Gürlich R; Haluzík M; Racek J; Vyhnankova I; Stollová M; Teplan V
    Wien Klin Wochenschr; 2010 Aug; 122(15-16):466-73. PubMed ID: 20658196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related kidney disease: Beyond hypertension and insulin-resistance.
    Arabi T; Shafqat A; Sabbah BN; Fawzy NA; Shah H; Abdulkader H; Razak A; Sabbah AN; Arabi Z
    Front Endocrinol (Lausanne); 2022; 13():1095211. PubMed ID: 36726470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal".
    Kataoka H; Nitta K; Hoshino J
    Front Med (Lausanne); 2023; 10():1179834. PubMed ID: 37521339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity-related glomerulopathy: Mechanisms of development, clinical course].
    Kutyrina IM
    Ter Arkh; 2017; 89(6):97-101. PubMed ID: 28745696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
    Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
    Rüster C; Wolf G
    Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines mediate inflammation and insulin resistance.
    Kwon H; Pessin JE
    Front Endocrinol (Lausanne); 2013; 4():71. PubMed ID: 23781214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin hormone a new molecular modulator between obesity and glomerular damage.
    Ibrahim M; Khalife L; Abdel-Latif R; Faour WH
    Mol Biol Rep; 2023 Dec; 50(12):10525-10533. PubMed ID: 37924451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism.
    Rodríguez A; Ezquerro S; Méndez-Giménez L; Becerril S; Frühbeck G
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E691-714. PubMed ID: 26330344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.